Form 4: Fairmount Converts Galecto Preferred Stock to Common
Insider Transaction
Fairmount Funds Management and affiliated entities converted Series C Preferred Stock into 8.7 million shares of Galecto, Inc. common stock following stockholder approval.
Summary
- Fairmount Funds Management LLC and its affiliated entities, Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest V L.P., converted Series C Non-Voting Convertible Preferred Stock into common stock of Galecto, Inc. (GLTO).
- The conversion took place on February 9, 2026, after receiving the requisite stockholder approval from Galecto, Inc.'s shareholders.
- Fairmount Healthcare Fund II L.P. converted 5,809 shares of Series C Preferred Stock into 5,809,000 shares of Common Stock.
- Fairmount Healthcare Co-Invest V L.P. converted 2,904 shares of Series C Preferred Stock into 2,904,000 shares of Common Stock.
- The conversion ratio was 1,000 shares of Common Stock for each share of Series C Preferred Stock.
- The newly acquired common stock, along with other securities held by the reporting persons, is subject to a 60-day lock-up agreement.
- This lock-up period commenced on February 10, 2026, following the date of the final prospectus supplement related to Galecto's public offering.
- Fairmount, Peter Harwin, and Tomas Kiselak disclaim beneficial ownership of the reported securities, except to the extent of their pecuniary interest.
- Fairmount, Fund II, and Co-Invest may be considered directors by deputization due to Peter Harwin's role on Galecto's board of directors and as a manager of Fairmount.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a largely procedural event, converting preferred shares to common after stockholder approval, which simplifies the capital structure. The lock-up agreement is standard for a recent public offering, making the overall sentiment neutral to slightly positive due to capital structure simplification.
Positives
- Stockholder approval for the conversion indicates alignment between the company and its shareholders regarding capital structure changes.
- The conversion of preferred stock into common stock simplifies Galecto's capital structure, potentially making it more transparent for investors.
Negatives
- The expiration of the 60-day lock-up period on approximately April 11, 2026, could lead to increased selling pressure on Galecto's common stock as significant holders gain the ability to sell their shares.
Risks
- Potential selling pressure on Galecto's common stock after the 60-day lock-up period expires around April 11, 2026, as Fairmount and its affiliates may then sell their substantial holdings.
- The Series C Preferred Stock conversion is subject to beneficial ownership limitations, preventing Fairmount and its affiliates from owning more than 19.99% of the outstanding common stock immediately after conversion, which could impact future conversion flexibility.
Future Outlook
The filing indicates that the significant block of common stock acquired through conversion is subject to a 60-day lock-up period, which will expire around April 11, 2026. This suggests that Galecto, Inc. recently completed a public offering, and the expiration of this lock-up will allow these major shareholders to potentially sell their shares, which could impact market dynamics.
Management Comments
- "Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein."
- "Fairmount, Fund II and Co-Invest may each be deemed a director by deputization of the Issuer by virtue of the fact that Peter Harwin serves on the board of directors of the Issuer and is a manager of Fairmount."
Industry Context
StockSavvy.ai notes that the conversion of preferred stock to common stock is a routine event, often occurring in conjunction with or following a public offering to simplify a company's capital structure. The imposition of a 60-day lock-up agreement on significant shareholders post-offering is a standard practice in the biotech and pharmaceutical sectors, designed to prevent immediate large-scale selling and help stabilize the stock price after a capital raise.
Comparison to Industry Standards
- The 1,000:1 conversion ratio for Series C Preferred Stock to Common Stock is specific to Galecto's capital structure and its original preferred stock terms, making direct comparison to a universal industry standard difficult without more context on the initial preferred stock issuance.
- A 60-day lock-up period, while common, is on the shorter side compared to the 90-180 day lock-up periods often seen for significant shareholders in biotech IPOs or follow-on offerings, such as those observed in recent offerings by emerging pharmaceutical companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Peter Harwin | NA | Clarification of director by deputization due to his role as a manager of Fairmount Funds Management LLC and service on the board. |
| Manager of Fairmount Funds Management LLC | NA | Tomas Kiselak | NA | Clarification of his role as a manager of Fairmount Funds Management LLC. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Stockholder Approval | Galecto's stockholders approved the issuance of Common Stock upon conversion of the Series C Non-Voting Convertible Preferred Stock. | February 9, 2026 | This approval streamlines the company's capital structure by allowing the conversion of preferred shares into publicly tradable common stock, aligning with corporate governance best practices for significant capital changes. |
Stakeholder Impact
- Shareholders: The conversion increases the number of outstanding common shares, which could lead to dilution for existing common shareholders. The temporary lock-up agreement prevents immediate selling pressure from these large holders, but its expiration could introduce volatility.
- Creditors: The conversion of preferred stock to common stock generally strengthens the equity base, which can be viewed positively by creditors as it reduces the company's fixed obligations associated with preferred dividends (if any) and simplifies the capital structure.
Next Steps
- Monitor the expiration of the 60-day lock-up period around April 11, 2026, as this date could mark a potential increase in selling activity from the reporting persons.
Key Dates
| Date | Description |
|---|---|
| 02/09/2026 | Date of earliest transaction, when Galecto's stockholders approved the conversion and the Series C Preferred Stock was converted into Common Stock. |
| 02/10/2026 | Date of the final prospectus supplement relating to Galecto's public offering, which initiated the 60-day lock-up period for the reporting persons' securities. |
| 02/12/2026 | Date the Form 4 was filed. |
| 04/11/2026 | Approximate expiration date of the 60-day lock-up period (60 days after February 10, 2026). |
Recommendation
holdThis Form 4 primarily reports a conversion of preferred stock to common stock by significant shareholders, a largely administrative event following stockholder approval. While it increases the float and the eventual expiration of the lock-up could introduce selling pressure, it doesn't fundamentally alter the company's operational or financial prospects in a way that warrants a strong buy or sell recommendation based solely on this filing. Investors should hold and monitor the company's core business performance and the impact of the recent public offering.
Keywords
Galecto, GLTO, Fairmount Funds Management, Series C Preferred Stock, Common Stock, Stock Conversion, SEC Form 4, Insider Transaction, 10% Owner, Director, Lock-up Agreement, Capital Structure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.